Ingrid Stacey (née Boehm)
Ingrid Stacey (née Boehm)
Cancer Institute of New South Wales
Verified email at wn.com.au
Title
Cited by
Cited by
Year
Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential
MA Bogoyevitch, I Boehm, A Oakley, AJ Ketterman, RK Barr
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1697 (1-2), 89-101, 2004
3192004
Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104
J Benito, Y Shi, B Szymanska, H Carol, I Boehm, H Lu, S Konoplev, ...
PloS one 6 (8), e23108, 2011
1182011
Rapid Detection of vanA and vanB Genes Directly from Clinical Specimens and Enrichment Broths by Real-Time Multiplex PCR Assay
S Palladino, ID Kay, JP Flexman, I Boehm, AMG Costa, EJ Lambert, ...
Journal of Clinical Microbiology 41 (6), 2483-2486, 2003
1162003
Association between tobacco plain packaging and Quitline calls: a population‐based, interrupted time‐series analysis
JM Young, I Stacey, TA Dobbins, S Dunlop, AL Dessaix, DC Currow
Medical Journal of Australia 200 (1), 29-32, 2014
982014
Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer
H Carol, I Boehm, CP Reynolds, MH Kang, JM Maris, CL Morton, ...
Cancer chemotherapy and pharmacology 68 (5), 1291-1304, 2011
922011
The anti-CD19 antibody–drug conjugate SAR3419 prevents hematolymphoid relapse postinduction therapy in preclinical models of pediatric acute lymphoblastic leukemia
H Carol, B Szymanska, K Evans, I Boehm, PJ Houghton, MA Smith, ...
Clinical Cancer Research 19 (7), 1795-1805, 2013
682013
The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK
RK Barr, I Boehm, PV Attwood, PM Watt, MA Bogoyevitch
Journal of Biological Chemistry 279 (35), 36327-36338, 2004
682004
Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts
S Suryani, H Carol, TN Chonghaile, V Frismantas, C Sarmah, L High, ...
Clinical Cancer Research 20 (17), 4520-4531, 2014
602014
Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts
B Szymanska, U Wilczynska-Kalak, MH Kang, NLM Liem, H Carol, ...
PloS one 7 (3), e33894, 2012
442012
Unconditional and conditional incentives differentially improved general practitioners' participation in an online survey: randomized controlled trial
JM Young, A O'Halloran, C McAulay, M Pirotta, K Forsdike, I Stacey, ...
Journal of clinical epidemiology 68 (6), 693-697, 2015
362015
High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus
FF Yuan, I Boehm, PKS Chan, K Marks, JW Tang, DSC Hui, JJY Sung, ...
Clinical and Vaccine Immunology 14 (12), 1644-1645, 2007
322007
Knowledge of the signs and symptoms and risk factors of lung cancer in Australia: mixed methods study
M Crane, N Scott, BJ O’Hara, S Aranda, M Lafontaine, I Stacey, M Varlow, ...
BMC public health 16 (1), 1-12, 2016
272016
Efficacy of CPX‐351,(cytarabine: daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program
H Carol, MMY Fan, TO Harasym, I Boehm, LD Mayer, P Houghton, ...
Pediatric blood & cancer 62 (1), 65-71, 2015
182015
Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture
JS Sullivan, PW Selleck, T Downton, I Boehm, AM Axell, Y Ayob, ...
Journal of molecular and genetic medicine: an international journal of …, 2009
182009
Contemporary incidence and prevalence of Rheumatic Fever and Rheumatic Heart Disease in Australia using linked data: the case for policy change
JM Katzenellenbogen, D Bond‐Smith, RJ Seth, K Dempsey, J Cannon, ...
Journal of the American Heart Association 9 (19), e016851, 2020
132020
Self-reported participation and beliefs about bowel cancer screening in New South Wales, Australia
M Varlow, I Stacey, S Dunlop, J Young, J Kite, A Dessaix, C McAulay
Health Promotion Journal of Australia 25 (2), 97-103, 2014
122014
Cross-reactive anti-avian H5N1 influenza neutralizing antibodies in a normal ‘exposure-naive’Australian blood donor population
GW Lynch, PW Selleck, AM Axell, T Downton, NM Kapitza, I Boehm, ...
The Open Immunology Journal 1 (1), 2008
112008
Development and Use of a Peptide Inhibitor of the c-Jun N-terminal kinase (JNK) Subfamily of Mitogen-Activated Protein Kinases
MA Bogoyevitch, RK Barr, RM Hopkins, PM Watt, I Boehm, A Chan, ...
Cellular and Molecular Biology Letters 8 (2A), 550-551, 2003
22003
Abstract C107: The anti-CD19 antibody-drug conjugate SAR3419 prevents hematolymphoid relapse post induction therapy in preclinical models of pediatric acute lymphoblastic leukemia.
RB Lock, H Carol, B Szymanska, I Boehm, K Evans, PJ Houghton, ...
Molecular Cancer Therapeutics 10 (11 Supplement), C107-C107, 2011
12011
CD14-159CC, another risk genotype for severe SARS-CoV infection
FF Yuan, I Boehm, PKS Chan, K Marks, JW Tang, DSC Hui, JJY Sung, ...
Clinical and Vaccine Immunology, 2007
12007
The system can't perform the operation now. Try again later.
Articles 1–20